Roivant Sciences (ROIV) Return on Sales (2020 - 2026)
Roivant Sciences' (ROIV) quarterly Return on Sales came in at 0.13% in Q3 2025, up 22.0% YoY from 0.1% in Q3 2024, and up 37.49% on a QoQ basis from 0.09% in Q2 2025.
Roivant Sciences (ROIV) Return on Sales (2020 - 2026) Analysis & Trends
Roivant Sciences (ROIV) has 6 years of Return on Sales data on file, last reported at 0.13% in Q3 2025.
- Quarterly Return on Sales rose 22.0% year-over-year to 0.13% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.13% (up 17.0% YoY) and the FY2025 annual result came in at 0.13%, up 22.0% from the prior year.
- Return on Sales rose to 0.13% in Q3 2025, from 0.09% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.17% in Q4 2024 to a low of 0.82% in Q2 2022.
- A 5-year average of 0.13% and a median of 0.13% in 2021 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2022 — Return on Sales slumped 69 bps — and 2023, when it surged 67 bps.
- Tracing ROIV's Return on Sales over 5 years: stood at 0.14% in 2021, then sank by 126 bps to 0.31% in 2022, then surged by 69 bps to 0.1% in 2023, then soared by 282 bps to 0.17% in 2024, then decreased by 28 bps to 0.13% in 2025.
- The last three Return on Sales figures came in at 0.13% (Q3 2025), 0.09% (Q2 2025), and 0.17% (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -2.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.02% |
| Sep 30, 2025 | 0.13% |
| Jun 30, 2025 | 0.09% |
| Dec 31, 2024 | 0.17% |
| Sep 30, 2024 | -0.10% |
| Jun 30, 2024 | 0.11% |
| Dec 31, 2023 | -0.10% |
| Sep 30, 2023 | -0.24% |
| Jun 30, 2023 | -0.15% |
| Dec 31, 2022 | -0.31% |
| Sep 30, 2022 | -0.25% |
| Jun 30, 2022 | -0.82% |
| Dec 31, 2021 | -0.14% |
| Sep 30, 2021 | -0.16% |
| Jun 30, 2021 | -0.13% |
| Dec 31, 2020 | -0.48% |
| Sep 30, 2020 | -0.40% |
| Jun 30, 2020 | -0.05% |